Press release
Global Migraine Market Report: 2016 Edition – New Report by Koncept Analytics
The report, “Global Migraine Market” analyzes the currently prevailing condition of the market along with its future scope of development.Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic Migraine (EM) are both part of the spectrum of migraine disorders, but are distinct clinical entities. The onset of migraine is preceded by certain triggers, which can be unique for each migraine sufferer.
The current market for migraine includes Triptans and Ergots as the most common treatment options. The market also currently faces several unmet needs and is saturated with generic drugs availability. Currently, there are several companies developing novel therapeutic compounds and devices to treat migraine. The focus of upcoming drugs is to either cure migraine or to reduce the frequency to a level where patients can find tolerable relief.
A modest growth in the overall market is anticipated driven by launch of new therapies and increasing rate of drug treatment and rising awareness among patients and physicians regarding migraine. The major growth drivers of the migraine market includes rising spending on medicines, growing female population, increasing cigarette consumption and healthcare expenditure. However, the growth of the market will also remain challenged by complications associated with Triptans, treatment limitations for patients with CV (Cardio Vascular) risk and increased preference for OTC (Over the Counter) medications.
The report, “Global Migraine Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific market of the U.S. is being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.
List of Charts
Global Migraine Drug Market by Value (2013-2020E)
Global Migraine Drug Market by Category (2015E)
Global Therapeutic Botulinum Toxin Market (2013-2020E)
Global Therapeutic Botulinum Toxin Market by Indication (2015)
The U.S. Total Migraine Population (2015-2022E)
The U.S. Migraine Population by Diagnosis (2015E)
The U.S. Migraine Population with CV Risk Factors (2015-2022E)
The U.S. Preventive Migraine Treatment by Specialty (2015)
The U.S. Acute Migraine Treated Population by Drug Type (2014)
The U.S. Acute Migraine Prescription Volume (2015-2025E)
The U.S. Cambia Drug Revenue (2015-2022E)
The U.S. Lasmiditan Drug Revenue & Treated Patient (2015-2022E)
Global Spending on Medicines (2010-2020E)
Pharmaceutical Spending Per Capita by Country (2015)
Global Female Population (2010-2015)
Global Cigarette Consumption (1910-2014)
Global Healthcare Expenditure (2010-2015E)
Global FDA Neuromodulator Trials by Category (2014)
Reasons for Initiation of VNS Therapy among Patients (2015)
Reasons for Continuation of VNS Therapy among Patients (2015)
Percentage of People Affected in the U.S. (2014)
Common Symptoms in Migraine Patients (2015)
Global Over the Counter (OTC) Drug Market (2010-2014)
Amgen Inc. Revenue Share by Geography (2015)
Amgen Inc. Revenue and Net Income (2011-2015)
Amgen Inc. Research and Development Expenditure (2011-2015)
Teva Pharmaceuticals Product Sales by Segment (2015)
Teva Pharmaceuticals Revenue and Net Income (2011-2015)
Teva Pharmaceuticals Research & Development Expenditure (2011-2015)
Eli Lilly Revenue by Segments (2015)
Revenue and Net Income of Eli Lilly and Company (2011-2015)
Research and Development Expenditure of Eli Lilly (2011-2015)
AstraZeneca Revenue by Therapeutic Segment (2015)
AstraZeneca Revenue by Regions (2015)
AstraZeneca Revenue and Net profit (2010-2015)
List of Tables
Common Migraine Triggers
Current Treatment Options for Moderate to Severe Episodic Migraine
Non-Triptans Migraine Drugs under Development
Global Migraine Competitors Comparison (2015)
Product and Other Acquisitions of Eli Lilly
Note: Purchase by Section Also Available
For more Information:
http://www.konceptanalytics.com/Researchreport/global-migraine-market-report-2016-edition-7278.aspx
Koncept Analytics
Vikas Gupta
(Business Development Manager)
FFCS-36, Ansal Plaza
Vaishali, Ghaziabad
U.P - 201010
Tele: +91-120-4130959
Mobile: +91-9811715635
Mail ID – vikas@konceptanalytics.com
Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:
http://www.konceptanalytics.com
Koncept Analytics
Vikas Gupta
(Business Development Manager)
http://www.konceptanalytics.com/Researchreport/global-migraine-market-report-2016-edition-7278.aspx
FFCS-36, Ansal Plaza
Vaishali, Ghaziabad
U.P - 201010
Tele: +91-120-4130959
Mobile: +91-9811715635
Mail ID – vikas@konceptanalytics.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Migraine Market Report: 2016 Edition – New Report by Koncept Analytics here
News-ID: 341931 • Views: …
More Releases from Koncept Analytics
Global Champagne Market Report: 2016 Edition – New Report by Koncept Analytics
The report offers an in-depth analysis of the global champagne market segmented into global wine market, global champagne market and regional champagne market.
Champagne is a vibrant, sparkling wine produced by natural yeast fermentation and is considered as a celebratory drink, forming a key component of the luxury spirit market. Only three grape varieties are permitted in the production of Champagne: Chardonnay (white/greenish grape), Pinot Noir (blue/reddish grape), and Pinot Meunier…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…